Rejection, Transplant Completed Phase 4 Trials for Sirolimus (DB00877)

Also known as: Transplant Rejection / Transplant rejections / Graft Rejection

IndicationStatusPhase
DBCOND0030946 (Rejection, Transplant)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00254709Study Evaluating Two Different Sirolimus-based Immunosuppressive Regimens in Elderly Kidney Transplant RecipientsTreatment
NCT00261820Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft RecipientsTreatment
NCT00266123Study Comparing Two Sirolimus Regimens vs. Tacrolimus and Mycophenolate Mofetil Regimen in Kidney Transplant RecipientsTreatment
NCT00369382Study Of The Safety And Efficacy Of Conversion From A CNI To Sirolimus In Renally-Impaired Heart Transplant RecipientsPrevention
NCT00895583Study Evaluating A Planned Transition From Tacrolimus To Sirolimus In Kidney Transplant RecipientsPrevention